Metraipolis › archive › dc_b200d9aa60da

Dose differences between patients treated with MR-only, CT-only, or MR-CT fusion radiotherapy for prostate cancer — Europe PMC PMID:40668761

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40668761
DOI
10.1093/bjr/tqaf159
License (as archived)
solo-consultazione
Archived
2026-11-08T03:33:08.219Z
SHA-256 of the archived text
612aa347e6716074b5b13cd259b363d04a55e139332a8c907b4f66503306bc69
Stable URL of this page
https://metraipolis.com/documento/dc_b200d9aa60da

How to cite

Dose differences between patients treated with MR-only, CT-only, or MR-CT fusion radiotherapy for prostate cancer — Europe PMC PMID:40668761 — Europe PMC (en), https://europepmc.org/article/MED/40668761 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b200d9aa60da (Metraipolis archive dc_b200d9aa60da, sha256 612aa347e6716074b5b13cd259b363d04a55e139332a8c907b4f66503306bc69)
BibTeX
@misc{dcb200d9aa60da,
  title = {Dose differences between patients treated with MR-only, CT-only, or MR-CT fusion radiotherapy for prostate cancer — Europe PMC PMID:40668761},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40668761},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b200d9aa60da; sha256 612aa347e6716074b5b13cd259b363d04a55e139332a8c907b4f66503306bc69},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40668761. Agents can read the archived copy with the MCP tool read_document.